Matthew K. Fust has been named executive vice president and chief financial officer of Onyx Pharmaceuticals. Mr. Fust will serve as Onyx’s principal financial and accounting officer and report to N. Anthony Coles, M.D., the company’s president and chief executive officer. “Matt is a proven leader who brings extensive senior management and operational experience to Onyx, as well as a shared strategic vision to create a leading biopharmaceutical company,” said Dr. Coles....